AbbVie's $16.7M Inversion Settlement Gets Initial Approval
An Illinois federal judge has given preliminary approval to a $16.75 million agreement to settle a claim that pharmaceutical maker AbbVie misled investors about risks of its failed $54 billion merger...To view the full article, register now.
Already a subscriber? Click here to view full article